Try our Advanced Search for more refined results

FDA Will Investigate Pharma Promo Caveats, 'Overwarnings'

By John Kennedy (June 16, 2017, 8:33 PM EDT) -- The U.S. Food and Drug Administration plans to investigate how prescribers use data presented as part of cancer drug promotions, as well as whether "overwarning" consumers will cause them to ignore warnings about drugs, the agency said in documents due to be published in the Federal Register on Monday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!